Hosono Naoko 細野奈穂子

… Alternative Names

細野奈穂子ホソノナオコ

Less

Researcher Number	50509312
Other IDs
Affiliation (Current)	2025: 福井大学, 学術研究院医学系部門(附属病院部), 講師
Affiliation (based on the past Project Information) *help	2017 – 2024: 福井大学, 学術研究院医学系部門(附属病院部), 講師 2016: 福井大学, 学術研究院医学系部門(附属病院部), 助教 2008 – 2009: University of Fukui, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related / Hematology Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 52040:Radiological sciences-related
Keywords	Principal Investigator 7番染色体 / 急性骨髄性白血病 / HSP90 / WT1 / mir-145 / DNA修復障害 / TGF-B / TGF－β / DNA修復 / TGF-β … More / miR-145 / ハプロ不全 / CUX1 / 発現制御 / 癌 / Luc7L2 / 骨髄系悪性腫瘍 / スプライスソーム / スプライシング / U1snRNP / LETMD1 / HMGN1 / スプライシング異常 / スプライシングの異常 / LUC7L2 / 骨髄系腫瘍 / GSTM1 / シグナル伝達 / 薬剤反応性 … More Except Principal Investigator 分子標的治療 / 急性白血病 / 血液腫瘍学 / 化学療法 / 免疫療法 / エピゲノム修飾 / アポトーシス抵抗性 / 薬物治療学 / 細胞療法 / 予測モデル / 造血活性 / 骨髄不全 / 骨髄不全症 / PET/MRI / FLT / 耐性克服 / 抗アポトーシスタンパク / クロファラビン / 分子標的療法 Less

新規薬物送達システムとエピゲノム制御による耐性急性白血病の新救援治療の確立
- Principal Investigator
  
  山内高弘
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Mechanism of HSP90-mediated induction of cell death in WT1 mutant/overexpressing leukemiaPrincipal Investigator
- Principal Investigator
  
  細野奈穂子
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  University of Fukui
Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.
- Principal Investigator
  
  Yamauchi Takahiro
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Mechanism of clonal evolution by both CUX1 and miR-145 haploinsufficiencyPrincipal Investigator
- Principal Investigator
  
  Hosono Naoko
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  University of Fukui
Quantitative assessment of bone marrow activity using 18F-FLT PET in bone marrow failure syndrome
- Principal Investigator
  
  Tsujikawa Tetsuya
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52040:Radiological sciences-related
- Research Institution
  University of Fukui
Pharmacologically-directed, novel strategy to overcome drug resistance in acute leukemia.
- Principal Investigator
  
  Yamauchi Takahiro
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  University of Fukui
Elucidating the mechanisms by which spliceosomal gene LUC7L2 defects causes myeloid neoplasmsPrincipal Investigator
- Principal Investigator
  
  Hosono Naoko
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  University of Fukui
新規グルココルチコイド耐性遺伝子GSTM1のアポトーシス抑制機構の解明Principal Investigator
- Principal Investigator
  
  細野奈穂子
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (Start-up)
- Research Field
  
  Hematology
- Research Institution
  University of Fukui

All 2024 2023 2022 2021 2020 2019 2018 2008 Other

All Journal Article Presentation

[Journal Article] Current status and prospects of novel molecular targeted therapy in AML2023
- Author(s)
  Hosono N
- Journal Title
  
  Annals of Oncology
  
  Volume: 34 Pages: S1369-S1369
- DOI
  10.1016/j.annonc.2023.09.079
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy2023
- Author(s)
  Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Maeda Y, Hosono N, Onozawa M, Kato T, Kim HJ, Hasabou N, Nuthethi R, Tiu R, Levis MJ.
- Journal Title
  
  Transplantation and Cellular Therapy
  
  Volume: 29 Issue: 4 Pages: 265.e1-265.e10
- DOI
  10.1016/j.jtct.2022.12.006
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging2023
- Author(s)
  Araie H、Hosono N、Tsujikawa T、Kiyono Y、Okazawa H、Yamauchi T
- Journal Title
  
  International Journal of Hematology
  
  Volume: 118 Issue: 5 Pages: 618-626
- DOI
  10.1007/s12185-023-03658-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI2023
- Author(s)
  Araie H、Hosono N、Tsujikawa T、Okazawa H、Yamauchi T
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 2272-2272
- DOI
  10.1182/blood-2023-173237
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 012023
- Author(s)
  Hosono Naoko、Chi SungGi、Yamauchi Takahiro、Fukushima Kentaro、Shibayama Hirohiko、Katagiri Seiichiro et al.
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 5 Pages: 2098-2108
- DOI
  10.1111/cas.15746
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07200, KAKENHI-PROJECT-21K08396, KAKENHI-PROJECT-21K07239
[Journal Article] NGS Profile and the Mathematical Prediction Model for Venetoclax Combination Therapy in HM-Screen-Japan 02 Study2023
- Author(s)
  Ueda Tomoaki、Fukushima Kentaro、Hosen Naoki、Chi Sunggi、Haeno Hiroshi、Yoshimoto Goichi、Arai Hironori、Ikeda Daisuke、Usuki Kensuke、Takahashi Naoto、Hosono Naoko、Yamauchi Takahiro、Kondo Takeshi、Yamamoto Kazuhito、Kuroda Junya、Minami Yosuke
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 5761-5761
- DOI
  10.1182/blood-2023-180339
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Phase 1/2 study of menin inhibitor DSP-5336 in acute leukemia with and without MLL rearrangement or NPM1 mutation2023
- Author(s)
  Daver N、Ikezoe T、Watts J、Hosono N、Ogawa Y、Miyazaki Y、Erba H、Affinito J、Cai H、Brooks E、Eguchi K、Stoudemire J、Watanabe A、Kuwaki T、Hitron M、Komarnitsky P、Yuda J
- Journal Title
  
  Annals of Oncology
  
  Volume: 34 Pages: S1456-S1456
- DOI
  10.1016/j.annonc.2023.09.383
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Combining Inotuzumab Ozogamicin (IO) with PARP Inhibitors, Olaparib and Talazoparib, Exerts Synergistic Cytotoxicity By Inhibiting the Repair of IO-Induced DNA Strand Breaks in IO-Resistant ALL Cells2023
- Author(s)
  Ida N、Okura M、Hosono N、Yamauchi T
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 5804-5804
- DOI
  10.1182/blood-2023-173907
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding2023
- Author(s)
  Naoe T, Saito A, Hosono N, Kasahara S, Muto H, Hatano K, Ogura M, Masunari T, Tanaka M, Usuki K, Ishikawa Y, Ando K, Kondo Y, Takagi Y, Takada S, Ishikawa M, Choi I, Sano A, Nagai H.
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 72 Issue: 8 Pages: 2865-2871
- DOI
  10.1007/s00262-023-03432-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18F-FLT PET/MRI2023
- Author(s)
  Araie Hi、Tasaki T、Hosono N、Tsujikawa T、Okazawa H、Yamauchi T
- Journal Title
  
  Annals of Hematology
  
  Volume: 102 Issue: 7 Pages: 1957-1959
- DOI
  10.1007/s00277-023-05224-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Practical and Flexible Genome Profiling Study Using the Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System: HM-Screen-JAPAN022023
- Author(s)
  Hosono N、Yamauchi T、Sung-Gi C、Arai H、Fukushima K、Ikeda D、Iyama S、Gotoh A、Ikezoe T、Yoshida C、Yoshimoto G、Kanda J、Takahashi N、Sakaida E、Usuki K、Minami Y
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 2279-2279
- DOI
  10.1182/blood-2023-184546
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia2023
- Author(s)
  Daver N, Zeidner JF, Yuda J, Watts JM, Levis MJ, Fukushima K, Ikezoe T, Ogawa Y, Brandwein J, Wang ES, Miyazaki Y, Pardee T, Hosono N, Shima T, Yokoyama H, Asada N, Jurcic J, Cai HL, Watanabe A, Hitron M, Brooks E, Xu B, Shah J, Kantarjian HM, Erba HP.
- Journal Title
  
  Blood
  
  Volume: 142 Issue: Supplement 1 Pages: 2911-2911
- DOI
  10.1182/blood-2023-179252
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial2022
- Author(s)
  Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu QY, Tiu R, Levis MJ.
- Journal Title
  
  Blood
  
  Volume: 139 Issue: 23 Pages: 3366-3375
- DOI
  10.1182/blood.2021011583
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan2022
- Author(s)
  Ikezoe T, Ando K, Onozawa M, Yamane T, Hosono N, Morita Y, Kiguchi T, Iwasaki H, Miyamoto T, Matsubara K, Sugimoto S, Miyazaki Y, Kizaki M, Akashi K.
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 12 Pages: 4258-4266
- DOI
  10.1111/cas.15458
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239, KAKENHI-PROJECT-22K19544, KAKENHI-PROJECT-21H02951
[Journal Article] Quantitative Assessment of Bone Marrow Activity Using 18F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes2022
- Author(s)
  Tasaki T, Tsujikawa T, Hosono N, Mori T, Makino A, Kiyono Y, Okazawa H, Yamauchi T.
- Journal Title
  
  Clinical Nuclear Medicine
  
  Volume: 47 Issue: 12 Pages: 1048-1055
- DOI
  10.1097/rlu.0000000000004419
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly2022
- Author(s)
  Arita K, Murakami J, Iwaki N, Hosono N, Tasaki T, Tsujikawa T, Okazawa H, Imi T, Nannya Y, Ogawa S, Nakao S.
- Journal Title
  
  British Journal of Haematology
  
  Volume: 198 Issue: 5
- DOI
  10.1111/bjh.18342
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib2022
- Author(s)
  Perl AE, Hosono N, Montesinos P, Podoltsev N, Martinelli G, Panoskaltsis N, Recher C, Smith CC, Levis MJ, Strickland S, Rollig C, Gross-Langenhoff M, Chou WC, Lee JH, Yokoyama H, Hasabou N, Lu QY, Tiu RV, Altman JK.
- Journal Title
  
  Blood Cancer Journal
  
  Volume: 12 Issue: 5 Pages: 84-84
- DOI
  10.1038/s41408-022-00677-7
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia2022
- Author(s)
  Katagiri Seiichiro、Chi SungGi、Minami Yosuke、Fukushima Kentaro、Shibayama Hirohiko、Hosono Naoko、Yamauchi Takahiro、Morishita Takanobu、Kondo Takeshi、Yanada Masamitsu、Yamamoto Kazuhito、Kuroda Junya、Usuki Kensuke、Akahane Daigo、Gotoh Akihiko
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 23 Issue: 9 Pages: 4694-4694
- DOI
  10.3390/ijms23094694
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07200, KAKENHI-PROJECT-21K07239
[Journal Article] Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.2021
- Author(s)
  Oiwa K, Hosono N, Nishi R, Scotto L, O’Connor OA, Yamauchi T.
- Journal Title
  
  BMC Cancer
  
  Volume: 21 Issue: 1
- DOI
  10.1186/s12885-021-08607-9
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience International Journal of Hematology.2021
- Author(s)
  Hosono N, Okura M, Morita H, Itoh K, Araie H, Matsuda Y, Yamauchi T.
- Journal Title
  
  Int J Hematol. 2021
  
  Volume: 113 Issue: 3 Pages: 362-369
- DOI
  10.1007/s12185-020-03023-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07239
[Journal Article] Population pharmacokinetic model development and exposure?response analysis of vincristine in patients with malignant lymphoma2021
- Author(s)
  Igarashi Toshiaki、Kishi Shinji、Hosono Naoko、Higashi Takashi、Iwao Takahiro、Yano Ryoichi、Tsukamoto Hitoshi、Goto Nobuyuki、Yamauchi Takahiro、Ueda Takanori
- Journal Title
  
  Cancer Chemotherapy and Pharmacology
  
  Volume: 87 Issue: 4 Pages: 501-511
- DOI
  10.1007/s00280-020-04220-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K14979, KAKENHI-PROJECT-21K07239
[Journal Article] Integrated [18F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology.2020
- Author(s)
  Tsujikawa T, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Rahman MGM, Yoshida Y, Yamauchi T, Kimura H, Okazawa H.
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 13878-13878
- DOI
  10.1038/s41598-020-70854-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08170, KAKENHI-PROJECT-20K09665, KAKENHI-PROJECT-18H02944
[Journal Article] Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.2020
- Author(s)
  Nishi R, Shigemi H, Negoro E, Okura M, Hosono N, Yamauchi T.
- Journal Title
  
  BMC Cancer.
  
  Volume: 20 Issue: 1
- DOI
  10.1186/s12885-020-07469-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] Genetic abnormalities and pathophysiology of MDS2019
- Author(s)
  Naoko Hosono
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 印刷中 Issue: 8 Pages: 885-892
- DOI
  10.1007/s10147-019-01462-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09844
[Journal Article] Distinct clinical and biological implications of CUX1 in myeloid neoplasms.2019
- Author(s)
  Aly M, Ramdzan ZM, Nagata Y, Balasubramanian SK, Hosono N, Makishima H, Visconte V, Kuzmanovic T, Adema V, Nazha A, Przychodzen BP, Kerr CM, Sekeres MA, Abazeed ME, Nepveu A, Maciejewski JP.
- Journal Title
  
  Blood Adv.
  
  Volume: 3 Issue: 14 Pages: 2164-2178
- DOI
  10.1182/bloodadvances.2018028423
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-19H01053
[Journal Article] Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.2019
- Author(s)
  Tsujikawa T, Oikawa H, Tasaki T, Hosono N, Tsuyoshi H, Yoshida Y, Yamauchi T, Kimura H, Okazawa H.
- Journal Title
  
  Eur J Radiol.
  
  Volume: 118 Pages: 223-230
- DOI
  10.1016/j.ejrad.2019.07.022
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294, KAKENHI-PROJECT-19K08170, KAKENHI-PROJECT-18H02944
[Journal Article] Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.2018
- Author(s)
  Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T.
- Journal Title
  
  Medicine (Baltimore)
  
  Volume: 97 Issue: 44 Pages: 12981-12981
- DOI
  10.1097/md.0000000000012981
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] <b>Febuxostat is useful for cancer-associated hyperuricemia in patients with hematologic malignancies</b>2018
- Author(s)
  Oiwa K, Morita M, Kawamichi M, Fujita K, Lee S, Negoro E, Ookura M, Matsuda Y, Tai K, Naoko Hosono N, Ueda T, Yamauchi T.
- Journal Title
  
  GOUT AND NUCLEIC ACID METABOLISM
  
  Volume: 42 Issue: 2 Pages: 157-164
- DOI
  10.6032/gnam.42.157
- NAID
  130007535820
- ISSN
  1344-9796, 2186-6368
- Year and Date
  2018-12-20
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07294
[Journal Article] 小児急性リンパ性白血病治療のpharmacogenetics2008
- Author(s)
  岸慎治, 細野奈穂子, 上田孝典, Mary V Relling
- Journal Title
  
  臨床薬理 39(4)
  
  Pages: 99-100
- NAID
  10026156946
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890089
[Journal Article] Gluthathione S-transferase M1 inhibits dexamethasone-induced apoptps is in association with the suppression of Bim through dual mechanisms in a Iympho blastic leukemia cell line
- Author(s)
  Hosono N., Kisi S., Iho S., Urasaki Y., Yoshida A., Kurooka H., Yokota Y., Ueda T.
- Journal Title
  
  Cancer Science (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20890089
[Presentation] Flexible genomic profiling study for AML regardless of test point: HM-SCREEN-JAPAN022024
- Author(s)
  細野奈穂子, 山内高弘, 池　成基, 新井宏典, 福島健太郎, 池田大輔, 井山　諭, 後藤明彦, 池添隆之, 吉田近思, 吉本五一, 諫田淳也, 高橋直人, 堺田惠美子, 臼杵憲祐, 南　陽介
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] NGS profile and the mathematical prediction model for venetoclax combination therapy in HM-SCREEN-Japan 02 study2024
- Author(s)
  上田智朗, 福島健太郎, 池　成基, 波江野洋, 吉本五一, 新井宏典, 池田大輔, 臼杵憲祐, 高橋直人, 細野奈穂子, 山内高弘, 近藤　健, 山本一仁, 黒田純也, 南　陽介
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] アザシチジンでベーチェット病類似症状が改善したトリソミー8陽性骨髄異形成症候群2024
- Author(s)
  山内英暉, 位田奈緒子, 新家裕朗, 森田美穂子, 松田安史, 根来英樹, 細野奈穂子, 山内高弘,内藤達志, 中本安成
- Organizer
  第252回日本内科学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Cellular uptake pathway and effect of CPX-351 in myelodysplastic syndrome patient-derived cell line2024
- Author(s)
  新家裕朗, 細野奈穂子, 山内高弘
- Organizer
  第21回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] HM02試験：ターゲットシークエンス解析に基づく造血幹細胞移植後予後層別化と臨床的意義2023
- Author(s)
  岩崎　惇, 諫田淳也, 池　成基, 森下喬允, 内藤知希, 池田大輔, 細野奈穂子, 山内高弘, 福島健太郎, 吉本五一, 吉満　誠, 柳田正光, 高橋直人, 堺田惠美子, 臼杵憲祐, 高折晃史, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性骨髄性白血病における骨髄異形成関連遺伝子の臨床的意義: HM-SCREEN-Japan 022023
- Author(s)
  内藤知希, 池　成基, 森下喬允, 後藤辰徳, 笠原史也, 小島研介, 山本　薫, 中邑幸伸, 金谷　穣, 近藤　健, 堀口拓人, 井山　諭, 鴨田吉正, 臼杵憲佑, 細野奈穂子, 山内高弘, 小林敬宏, 山下鷹也, 池田大輔, 吉本五一, 諫田淳也, 新井宏典, 宇津欣和, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 西田徹也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 緊急輸血患者の血液型判定に苦慮した一例2023
- Author(s)
  漆﨑絵理花, 福嶋祐喜, 増永志穂, 山田恵美子, 海老田ゆみえ, 細野奈穂子, 山内高弘
- Organizer
  第41回日本輸血・細胞治療学会北陸支部例会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia2023
- Author(s)
  Daver N, Zeidner JF, Yuda J, Watts JM, Levis MJ, Fukushima K, Ikezoe T, Ogawa Y, Brandwein J, Wang ES, Miyazaki Y, Pardee TS, Hosono N, Shima T, Yokoyama H, Asada N, Jurcic J, Cai HL, Watanabe A, Hitron M, Brooks E, Xu B, Shah J, Kantarjian HM, Erba HP.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] ミコフェノール酸モフェチルが著効した難治性免疫性血小板減少性紫斑病の一例2023
- Author(s)
  友田萌水, 塚本裕貴, 細野奈穂子, 知野剛直, 根来英樹, 山内高弘
- Organizer
  医学生・研修医・専攻医の日本内科学会ことはじめ2023東京
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] MLLr又はNPM1mが陽性又は陰性の急性白血病を対象としたDSP-5336の第1/2相試験2023
- Author(s)
  湯田淳一朗, Joshua Zeidner, Harry Erba, Justin Watts, 福島健太郎, 小川吉明, Mark Levis, 池添隆之, Joseph Brandwein, 細野奈穂子, et al.
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 移植前に潜在性甲状腺機能低下症を認めた急性骨髄性白血病患者が臍帯血移植後の早期2023
- Author(s)
  塚本裕貴, 新家裕朗, 松本玲奈, 中屋隆裕, 大蔵美幸, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第45回日本造血・免疫細胞療法学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] AGILE:IDH-1変異を有する新規AML患者に対するivosidenib+AZA群とプラセボ+AZA群の国際共同第3相比較試験2023
- Author(s)
  平松靖史, 細野奈穂子, 浦田真吾, 石川隆之, 臼杵憲祐, 牧田雅典, et al.
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] アザシチジン/ベネトクラクス療法におけるリアルワールドNGSプロファイル: HM-SCREEN-Japan 02 study2023
- Author(s)
  上田智朗, 福島健太郎, 池　成基, 吉本五一, 新井宏典, 池田大輔, 臼杵憲祐, 高橋直人, 細野奈穂子, 山内高弘, 近藤　健, 山本一仁, 黒田純也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] AMLにおけるコンパニオン診断（CDx）、どの症例にどのタイミングで？2023
- Author(s)
  細野奈穂子
- Organizer
  第85回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 治療が先行してもランダム皮膚生検が有用であった血管内大細胞性リンパ腫の1例2023
- Author(s)
  長谷川竜也，玉　直人，松田安史，松本玲奈，細野奈穂子
- Organizer
  第250回日本内科学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI2023
- Author(s)
  Araie H, Hosono N, Tsujikawa T, Okazawa H, Yamauchi T.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 18F-FLT PETが示した臍帯血移植における生着後も持続する脾臓での髄外造血の可能性2023
- Author(s)
  新家裕朗, 細野奈穂子, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] オビニツズマブによる維持療法中にCOVID19感染を発症した濾胞性リンパ腫2023
- Author(s)
  田中　周，根来英樹，松本玲奈，新家裕朗，森田美穂子，松田安史，細野奈穂子，酒巻一平，岩崎博道，山内高弘
- Organizer
  第250回日本内科学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Practical and Flexible Genome Profiling Study Using the Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System: HM-Screen-JAPAN022023
- Author(s)
  Hosono N, Yamauchi T, Chi SG, Arai H, Fukushima K, Ikeda D, Iyama S, Gotoh A, Ikezoe T, Yoshida C, Yoshimoto G, Kanda J, Takahashi N, Sakaida E, Usuki K, Minami Y.
- Organizer
  the 65th ASH Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 非重症再生不良性貧血に対するシクロスポリン療法の有用性に関する検討2023
- Author(s)
  山口博樹, 石山　謙, 山崎雅英, 丸山裕之, 細野奈穂子, 臼杵憲祐, 谷本一樹, 杉浦弘幸, 淺田　騰, 吉村健一, 小川誠司, 金倉　譲, 松村　到, 赤司浩一, 中尾眞二
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] デニロイキンジフチトクスで長期に病勢コントロールできた同種移植後再発末梢性T細胞リンパ腫2023
- Author(s)
  山内英暉, 松本玲奈, 細野奈穂子, 塚本裕貴, 河合泰一, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 急性骨髄性白血病におけるアクショナブル変異と新規治療2023
- Author(s)
  池成基, 新井宏典, 宇津欣和, 池田大輔, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 細野奈穂子, 山内高弘, 吉本五一, 小林敬宏, 高橋直人, 堀口拓人, 井山諭, 諫田淳也, 近藤健, 伊豆津宏二, 湯田淳一朗, 南陽介
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] イノツズマブオゾガマイシンとPARP阻害剤の併用によるDNA修復阻害を介した抗腫瘍効果の増強2023
- Author(s)
  位田奈緒子, 大蔵美幸, 細野奈穂子, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Ph陽性ALLに対するTKI治療が奏効した腹腔内平滑筋肉腫2023
- Author(s)
  位田奈緒子, 松本玲奈, 大蔵美幸, 松田安史, 森田美穂子, 根来英樹, 細野奈穂子, 小練研司, 五井孝憲, 山内高弘
- Organizer
  第41回日本血液学会北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] AML診療におけるターゲットシーケンス解析の有用性：HM-SCREEN-Japan02試験2023
- Author(s)
  細野奈穂子, 山内高弘, 池　成基, 新井宏典, 福島健太郎, 井山　諭, 後藤明彦, 池添隆之,吉田近思, 吉本五一, 諫田淳也, 高橋直人, 堺田惠美子, 臼杵憲祐, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] PCNSLに対しチラブルチニブ単剤で全身状態改善が得られた一例2023
- Author(s)
  田中　周, 位田奈緒子, 山内英暉, 松本玲奈, 新家裕朗, 森田美穂子, 松田安史, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 初発AML症例における初回寛解導入不応と遺伝学的解析との比較：HM-SCREEN-Japan 022023
- Author(s)
  森下喬允, 池　成基, 内藤知希, 後藤辰徳, 小笠原史也, 小島研介, 山本　薫, 中邑幸伸, 金谷　穣, 近藤　健, 堀口拓人, 井山　諭, 鴨田吉正, 臼杵憲祐, 細野奈穂子, 山内高弘, 小林敬宏, 山下鷹也, 池田大輔, 吉本五一, 諫田淳也, 新井宏典, 宇津欣和, 上田智朗, 福島健太郎, 小山大輔, 池添隆之, 西田徹也, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 自己免疫異常を伴うMDSは低リスク群でもアザシチジンが適する可能性があると思われた数症例2023
- Author(s)
  松田安史, 田中　周, 山内英暉, 位田奈緒子, 松本玲奈, 新家裕朗, 森田美穂子, 廣田智哉,根来英樹, 細野奈穂子, 山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 福井県における同種造血幹細胞移植の現状2023
- Author(s)
  松本玲奈, 塚本裕貴, 位田奈緒子, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第45回日本造血・免疫細胞療法学会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 尿酸値とキサンチン値が腫瘍崩壊症候群に対する薬剤選択に関与する2023
- Author(s)
  森田美穂子, 牧野嶋秀樹, 成田美優, 松本玲奈, 新家裕朗, 松田安史, 細野奈穂子, 根来英樹,山内高弘
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 持続型G-CSF製剤投与後に毛細血管漏出症候群を発症したびまん性大細胞型B細胞リンパ腫の一例2023
- Author(s)
  中野悠太郎, 塚本裕貴, 松田安史, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  医学生・研修医・専攻医の日本内科学会ことはじめ2023東京
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 不規則抗体陽性患者における適合血不応例2023
- Author(s)
  増永志穂, 漆崎絵理花, 福嶋祐喜, 海老田ゆみえ, 細野奈穂子, 山内高弘, 浦崎芳正, 吉川利英
- Organizer
  第71回日本輸血・細胞治療学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] NGS解析によるAMLの2022年ELNリスク分類の評価：HM-SCREEN-JAPAN022023
- Author(s)
  池田大輔, 池　成基, 新井宏典, 細野奈穂子, 山内高弘, 福島健太郎, 井山　諭, 吉本五一,高橋直人, 塚本祥吉, 臼杵憲祐, 末永孝生, 南　陽介
- Organizer
  第85回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 新規白血病治療薬であるリポソーム製剤:CPX-351におけるProtein corona解析とScavenger receptor class B type 1を介した細胞内取り込みの検討2023
- Author(s)
  新家裕朗, 細野奈穂子, 山内高弘
- Organizer
  第23回日本DDS学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] HM-SCREEN-Japan 01: a mutation profiling multicenter study on patients with acute myeloid leukemia2022
- Author(s)
  Hosono N, Yamauchi T, Chi S, Katagiri S, Gotoh A, Eguchi M, Morishita T, Ogasawara R, Kondo T, Yanada M, Yamamoto K, Kobayashi T, Kuroda J, Usuki K, Utsu Y, Aotsuka N, Yoshimitsu M, Ishitsuka K, Ono T, Minami Y
- Organizer
  19th Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of gut acute GVHD by diffusion weighted imaging with background signal suppression2022
- Author(s)
  新家裕朗, 細野奈穂子, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Analysis of WT1 mutations and expression in R/R-AML and newly diagnosed unfit AML: HM-SCREEN-Japan 012022
- Author(s)
  細野奈穂子, 山内高弘, 池成基, 福島健太郎, 柴山浩彦, 片桐誠一朗, 後藤明彦, 江口基紀, 森下喬允, 小笠原励起, 近藤健, 柳田正光, 山本一仁, 古林勉, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中邑幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一郎, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Tumor-agnostic actionable gene mutations including BRCA in acute myeloid leukemia: HM-SCREEN-JAPAN012022
- Author(s)
  新井宏典, 宇津欣和, 増田真一, 青墳信之, 福島健太郎, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 江口基紀, 森下喬允, 近藤健, 柳田正光, 山本一仁, 黒田純也, 臼杵憲祐, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 中邑幸伸, 福原傑, 伊豆津宏二, 池成基, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Liver iron quantification using MRI R2* mapping in aplastic anemia and myelodysplastic syndromes2022
- Author(s)
  塚本裕貴, 細野奈穂子, 松本玲奈, 新家裕朗, 多崎俊樹, 森田美穂子, 松田安史, 根来英樹, 辻川哲也, 岡沢秀彦, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Prognostic impact of mutant FLT3 variant allelic frequency in R/R AML/newly diagnosed unfit AML2022
- Author(s)
  福島健太郎, 江口基紀, 森下喬允, 池成基, 上田智朗, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 近藤健, 柳田正光, 山本一仁, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中村幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 悪性リンパ腫成人患者におけるvincristine TDMのためのlimited sampling strategyの検討2022
- Author(s)
  五十嵐敏明, 岸愼治, 細野奈穂子, 後藤伸之, 山内高弘
- Organizer
  第6回日本臨床薬理学会　東海・北陸地方会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] オモテ・ウラ検査不一致を呈し緊急に異型適合血を輸血した1症例2022
- Author(s)
  海老田ゆみえ, 漆崎絵理香, 大嶋祐喜, 増永志穂, 細野奈穂子, 前田典江, 松本玲奈, 新家裕朗, 森田美穂子, 松田安史, 根来英樹, 浦崎芳正, 山内高弘
- Organizer
  第70回日本輸血・細胞治療学会学術総会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Background of HM-SCREEN-JAPAN02: a practice-oriented rapid gene-testing study2022
- Author(s)
  池成基, 福島健太郎, 上田智朗, 片桐誠一朗, 後藤明彦, 細野奈穂子, 山内高弘, 塚本祥吉, 栢森健介, 竹田勇輔, 坪田惠美子, 小山大輔, 池添隆之, 吉田近思, 諫田淳也, 池田大輔, 小林敬宏, 山下鷹也, 高橋直人, 吉本五一, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一郎, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] The Effect of dexamethasone on attenuating vascular pain associated with bendamustine administration2022
- Author(s)
  根来英樹, 塚本裕貴, 位田奈緒子, 松本玲奈, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 上田孝典, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Evaluation of ELN classification with NGS analysis in AML: HM-SCREEN-JAPAN012022
- Author(s)
  池田大輔, 池成基, 福島健太郎, 柴山浩彦, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 森下喬允, 近藤健, 柳田正光, 山本一仁, 古林勉, 黒田純也, 臼杵憲祐, 宇津欣和, 吉満誠, 石塚賢治, 小野孝明, 高橋直人, 井山諭, 小島研介, 中邑幸伸, 福原傑, 伊豆津宏二, 山内寛彦, 湯田淳一朗, 南陽介
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] The duration of hospitalization with AZA or in combination with venetoclax for the treatment of AML2022
- Author(s)
  松本玲奈, 塚本裕貴, 新家裕朗, 松田安史, 森田美穂子, 細野奈穂子, 根来英樹, 山内高弘
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] TLS related serum metabolomic analysis identified specific changes in purine and amino acids2022
- Author(s)
  森田美穂子, 塚本裕貴, 松本玲奈, 新家裕朗, 松田安史, 細野奈穂子, 根来英樹, 山内高弘, 牧野嶋秀樹, 成田美優
- Organizer
  第84回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] 5.Outcomes in patients with R/R AML treated with gilteritinib after prior midostaurin or sorafenib.2021
- Author(s)
  細野奈穂子、山内高弘
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07239
[Presentation] Lineage switchをきたした治療抵抗性の急性白血病2020
- Author(s)
  久世彩歌，位田奈緒子，根来英樹，細野奈穂子，山内高弘
- Organizer
  日本内科学会ことはじめ 2020
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Current status and issues of discarding autologous blood in predeposit autologous blood transfusion2020
- Author(s)
  松田安史　位田奈緒子　新家裕朗　森田美穂子　大蔵美幸　根来英樹　細野奈穂子　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] FLT PETを用いた再生不良性貧血と骨髄異形成症候群の病態評価2020
- Author(s)
  辻川哲也、多崎俊樹、細野奈穂子、岡沢秀彦、山内高弘
- Organizer
  第61回日本核医学会学術総会
- Data Source
  KAKENHI-PROJECT-19K08170
[Presentation] 急性骨髄性白血病におけるFlt3変異の重要性：HM-SCREEN 01試験の中間解析より2020
- Author(s)
  福島健太郎, 柴山浩彦, 宮本憲一, 細野奈穂子, 山内高弘, 片桐誠一朗, 後藤明彦, 森下喬允, 柳田正光, 山本一仁, 藤島直仁, 高橋直人, 小笠原励起, 近藤健, 宇津欣和, 青墳信之, 臼杵憲祐, 小野孝明, 古林勉, 黒田純也, 堀口拓人, 井山諭, 福原傑, 伊豆津宏二, 神原悠輔, 江口基紀, 湯田淳一朗, 山内寛彦, 南陽介
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 急性白血病化学療法時の真菌感染症管理の実態：JALSGアンケート調査20192020
- Author(s)
  細野奈穂子, 木村俊一, 藤田浩之, 半田　寛, 平本展大, 南口仁志, 高橋　勉, 加藤英明, 小野孝明, 神田善伸, 清井　仁, 松村　到, 宮﨑泰司
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] T細胞リンパ腫細胞株におけるDarinaparsinと他の新規末梢T細胞リンパ腫化学療法薬との併用効果の検討2020
- Author(s)
  根来英樹　浦崎芳正　位田奈緒子　新家裕朗　大蔵美幸　松田安史　森田美穂子　細野奈穂子　上田孝典　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Integrated 18F-FDG PET/MRI demonstrates the iron-related bone-marrow physiology2020
- Author(s)
  Tetsuya Tsujikawa, Hiroshi Oikawa, Toshiki Tasaki, Naoko Hosono, Hideaki Tsuyoshi, Mahmudur G. M. Rahman, Yoshio Yoshida, Takahiro Yamauchi, Hirohiko Kimura, Hidehiko Okazawa
- Organizer
  第79回日本医学放射線学会総会
- Data Source
  KAKENHI-PROJECT-19K08170
[Presentation] The fluctuant quality of protective environment affected by seasons and office hours2020
- Author(s)
  新家裕朗　位田奈緒子　大蔵美幸　松田安史　森田美穂子　根来英樹　細野奈穂子　稲井邦博　岩崎博道　山内高弘
- Organizer
  第82回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Genomic Analysis of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 012020
- Author(s)
  Fukushima K, Chi S, Shibayama H, Hosono N, Yamauchi T, Katagiri S, Gotoh A, Morishita T, Yanada M, Yamamoto K, Fujishima N, Takahashi N, Ogasawara R, Kondo T, Utsu Y, Aotsuka N, Usuki K, Ono T, Kobayashi T, Kuroda J, Horiguchi H, Iyama S, Fukuhara S, Izutsu K, Nakamura M, Kojima K, Miyamoto K, Minami Y
- Organizer
  62nd American Society of Hematology, Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Treatment strategy for AML in Japan2020
- Author(s)
  Hosono Naoko
- Organizer
  第82回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] AMLに対する新規治療薬2019
- Author(s)
  細野奈穂子
- Organizer
  第81回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Gilteritinib Significantly prolongs overall survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukemia: results from the phase 3 ADMIRAL trial.2019
- Author(s)
  Hosono N, Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, Fabbiano F, Erba HP, Di Stasi A, Stuart R, Olin R, Kasner M, Ciceri F, Chou WC, Podoltsev N, Recher C, Yokoyama H, Yoon SS, Lee JH, Pardee T, Fathi AT, Liu C, Hasabou N, Liu X, Bahceci E, Levis MJ.
- Organizer
  15th National conference on leukemia and lymphoma
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity2019
- Author(s)
  Tetsuya Tsujikawa , Hiroshi Oikawa , Toshiki Tasaki , Naoko Hosono , Hideaki Tsuyoshi , Yoshio Yoshida , Takahiro Yamauchi , Hirohiko Kimura , Hidehiko Okazawa
- Organizer
  第78回日本医学放射線学会総会
- Data Source
  KAKENHI-PROJECT-19K08170
[Presentation] 急性骨髄性白血病、新規薬剤による新時代の幕開け2019
- Author(s)
  細野奈穂子
- Organizer
  第40回日本臨床薬理学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Direct comparison of factors related to bone marrow FDG uptake and MR signals using integrated PET/MRI2019
- Author(s)
  Tetsuya Tsujikawa, Hiroshi Oikawa, Toshiki Tasaki, Naoko Hosono, Takahiro Yamauchi, Hidehiko Okazawa
- Organizer
  第14回日本分子イメージング学会
- Data Source
  KAKENHI-PROJECT-19K08170
[Presentation] 急性骨髄性白血病および骨髄異形成症候群に対する治療薬の進歩2019
- Author(s)
  細野奈穂子
- Organizer
  第40回日本臨床薬理学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Bcl-2 inhibitor venetoclax augments cytotoxicity of cytarabine and clofarabine in drug-resistant leukemic cells in vitro.2018
- Author(s)
  Rie Nishi, Naoko Hosono, Hiroko Shigemi, Takanori Ueda, Takahiro Yamauchi.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] 急性骨髄性白血病における治療課題と今後の展望～FLT3阻害薬ギルテリチニブによる新たな治療戦略～2018
- Author(s)
  細野奈穂子
- Organizer
  第77回日本血液学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Pralatrexate-Resistant Cell Lines Show Intact Internalization Via RFC1 but Collateral Sensitivity to Nucleoside Analogs2018
- Author(s)
  Kana Oiwa, Naoko Hosono, Rie Nishi, Takanori Ueda, Luigi Scott, Owen A. O'Connor, Takahiro Yamauchi.
- Organizer
  第60回米国血液学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294
[Presentation] Spliceosomal gene LUC7L2 defect causes alteration of NOTCH3 and BIM expression in myeloid leukemia cell lines2018
- Author(s)
  Naoko Hosono
- Organizer
  The 9th JSH International Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09844
[Presentation] Establishment and characterization of Leukemic Cell Lines Resistant to New-Generation Dihydrofolate Reductase Inhibitor, Pralatrexate.2018
- Author(s)
  Kana Oiwa, Naoko Hosono, Rie Nishi, Takanori Ueda, Takahiro Yamauchi.
- Organizer
  18th World Congress of Basic and Clinical Pharmacology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07294

1. Yamauchi Takahiro (90291377)

# of Collaborated Projects: 3 results

# of Collaborated Products: 63 results
2. 根来英樹 (40444228)

# of Collaborated Projects: 2 results

# of Collaborated Products: 21 results
3. Tsujikawa Tetsuya (30380033)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
4. 森哲也 (40397287)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 大藏美幸 (30647657)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
6. 南陽介 (60513752)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 片桐誠一朗

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 塚本仁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 後藤明彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hosono Naoko 細野 奈穂子

細野 奈穂子 ホソノ ナオコ

Research Projects

Research Products

Co-Researchers

新規薬物送達システムとエピゲノム制御による耐性急性白血病の新救援治療の確立

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of HSP90-mediated induction of cell death in WT1 mutant/overexpressing leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pharmacologically-directed termination of anti-apoptosis to overcome drug resistance in acute leukemia.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mechanism of clonal evolution by both CUX1 and miR-145 haploinsufficiencyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Quantitative assessment of bone marrow activity using 18F-FLT PET in bone marrow failure syndrome

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pharmacologically-directed, novel strategy to overcome drug resistance in acute leukemia.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidating the mechanisms by which spliceosomal gene LUC7L2 defects causes myeloid neoplasmsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

新規グルココルチコイド耐性遺伝子GSTM1のアポトーシス抑制機構の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Current status and prospects of novel molecular targeted therapy in AML2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Evaluation of Hematopoiesis and Disease Status in Patients with Hematologic Malignancies Using Whole-Body Bone Marrow Imaging with 18 F-FLT PET/MRI2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 012023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NGS Profile and the Mathematical Prediction Model for Venetoclax Combination Therapy in HM-Screen-Japan 02 Study2023

Author(s)

Hosono Naoko 細野奈穂子

細野奈穂子ホソノナオコ